Phar­ma 'greed' emerges as a po­tent po­lit­i­cal is­sue in a rau­cous elec­tion year

Phar­ma ex­ecs aren’t the most pop­u­lar peo­ple in the US these days, par­tic­u­lar­ly when they keep hik­ing the price of their drugs. And a sen­ate …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.